These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38081200)

  • 41. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
    Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
    Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between oncological outcomes of patients with colorectal liver metastasis and additional gadoxetic acid-enhanced magnetic resonance imaging.
    D'Silva M; Cho JY; Han HS; Yoon YS; Lee HW; Lee JS; Lee B; Kim M
    Ann Palliat Med; 2021 Oct; 10(10):10213-10221. PubMed ID: 34498476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer.
    Hwang JA; Kim YK; Min JH; Song KD; Sohn I; Ahn HS
    Acta Radiol; 2019 Apr; 60(4):441-450. PubMed ID: 30130970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Additional value of gadoxetic acid-enhanced MRI to conventional extracellular gadolinium-enhanced MRI for the surgical management of colorectal and neuroendocrine liver metastases.
    Morin C; Drolet S; Daigle C; Deshaies I; Ouellet JF; Ball CG; Dixon E; Marceau J; Ouellet JB
    HPB (Oxford); 2020 May; 22(5):710-715. PubMed ID: 31640929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey.
    Bipat S; van Leeuwen MS; Ijzermans JN; Bossuyt PM; Greve JW; Stoker J
    Neth J Med; 2006 May; 64(5):147-51. PubMed ID: 16702613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT.
    Yoon JH; Lee JM; Chang W; Kang HJ; Bandos A; Lim HJ; Kang SY; Kang KW; Ryoo SB; Jeong SY; Park KJ
    Radiology; 2020 Feb; 294(2):310-319. PubMed ID: 31793850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.
    Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S
    JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
    Yu MH; Lee JM; Hur BY; Kim TY; Jeong SY; Yi NJ; Suh KS; Han JK; Choi BI
    Eur Radiol; 2015 Aug; 25(8):2428-36. PubMed ID: 25899413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-body MRI added to gadoxetic acid-enhanced liver MRI for detection of extrahepatic disease in patients considered eligible for hepatic resection and/or local ablation of colorectal cancer liver metastases.
    Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Mortensen FV; Pedersen EM
    Acta Radiol; 2020 Feb; 61(2):156-167. PubMed ID: 31189329
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
    Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
    Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
    Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
    AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.
    Tsili AC; Alexiou G; Naka C; Argyropoulou MI
    Acta Radiol; 2021 Mar; 62(3):302-312. PubMed ID: 32506935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.
    Vreugdenburg TD; Ma N; Duncan JK; Riitano D; Cameron AL; Maddern GJ
    Int J Colorectal Dis; 2016 Nov; 31(11):1739-1749. PubMed ID: 27682648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
    Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis.
    Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Matsueda K; Saiura A
    Ann Surg; 2015 Dec; 262(6):1086-91. PubMed ID: 26010441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
    Bartolozzi C; Donati F; Cioni D; Procacci C; Morana G; Chiesa A; Grazioli L; Cittadini G; Cittadini G; Giovagnoni A; Gandini G; Maass J; Lencioni R
    Eur Radiol; 2004 Jan; 14(1):14-20. PubMed ID: 14730384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
    Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
    Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.